Loss of Villin Immunoexpression in Colorectal Carcinoma Is Associated with Poor Differentiation and Survival
Table 1
Clinicopathological characteristics of cases.
Item
Number (%)
Age
<60 years
45/93 (48.4%)
≥60 years
48/93 (51.6%)
Sex
Male
44/93 (47.3%)
Female
49/93 (52.7%)
Tumour location
Right colon
30/93 (32.2%)
Left colon
26/93 (28%)
Rectum
37/93 (39.8%)
Tumour size
<5 cm
29/93 (31.2%)
≥5 cm
24/93 (25.8%)
Data not applicable
40/93 (43%)
Primary tumour
T1
0/93 (0%)
T2
12/93 (12.9%)
T3
10/93 (10.8%)
T4
31/93 (33.3%)
Data not applicable
40/93 (43%)
Tumour grade
Well differentiated
25/93 (26.9%)
Moderately differentiated
63/93 (67.7%)
Poorly differentiated
5/93 (5.4%)
Nodal metastasis
Positive
31/93 (33.3%)
Negative
24/93 (25.8%)
Data not applicable
38/93 (40.9%)
Lymphovascular invasion
Positive
7/93 (7.5%)
Negative
46/93 (49.5%)
Data not applicable
40/93 (43%)
Margin status
Involved
6/93 (6.5%)
Free
47/93 (50.5%)
Data not applicable
40/93 (43%)
Recurrence
Recurrence
30/93 (32.25%)
No recurrence
33/93 (35.5%)
Data not available
30/93 (32.25%)
Status at end point
Died of disease
23/93 (24.7%)
Alive
70/93 (75.3%)
T1: tumour invades submucosa; T2: tumour invades muscularis propria; T3: tumour invades through the muscularis propria into the subserosa or into nonperitonealised pericolic or perirectal tissues; T4: tumour directly invades other organs or structures and/or perforates visceral peritoneum.
